ANAVEX LIFE SCIENCES CORP. Research and Development Arrangement, Contract to Perform for Others, Compensation Earned
ANAVEX LIFE SCIENCES CORP. (AVXL) reported Research and Development Arrangement, Contract to Perform for Others, Compensation Earned of $30.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-28.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned · last filed 2026-08-28
- ANAVEX LIFE SCIENCES CORP. research and development arrangement, contract to perform for others, compensation earned for the quarter ending 2026-06-30 was $30.00K, a 70.00% decline year-over-year.
- ANAVEX LIFE SCIENCES CORP. research and development arrangement, contract to perform for others, compensation earned for the quarter ending 2026-03-31 was $30.00K, a 70.00% decline year-over-year.
- ANAVEX LIFE SCIENCES CORP. research and development arrangement, contract to perform for others, compensation earned for the quarter ending 2025-12-31 was $30.00K, a 92.50% decline year-over-year.
- ANAVEX LIFE SCIENCES CORP. research and development arrangement, contract to perform for others, compensation earned for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- ANAVEX LIFE SCIENCES CORP. research and development arrangement, contract to perform for others, compensation earned for fiscal 2025 was $600.00K, a 73.91% decline from fiscal 2024.
- ANAVEX LIFE SCIENCES CORP. research and development arrangement, contract to perform for others, compensation earned for fiscal 2024 was $2.30M, a 14.81% decline from fiscal 2023.
- ANAVEX LIFE SCIENCES CORP. research and development arrangement, contract to perform for others, compensation earned for fiscal 2023 was $2.70M, a 18.18% decline from fiscal 2022.
- ANAVEX LIFE SCIENCES CORP. research and development arrangement, contract to perform for others, compensation earned for fiscal 2022 was $3.30M, a 26.67% decline from fiscal 2021.
| Period end | Research and Development Arrangement, Contract to Perform for Others, Compensation Earned 3 month | Research and Development Arrangement, Contract to Perform for Others, Compensation Earned 3 month as first filed | Research and Development Arrangement, Contract to Perform for Others, Compensation Earned 6 month | Research and Development Arrangement, Contract to Perform for Others, Compensation Earned 6 month as first filed | Research and Development Arrangement, Contract to Perform for Others, Compensation Earned 9 month | Research and Development Arrangement, Contract to Perform for Others, Compensation Earned 9 month as first filed | Research and Development Arrangement, Contract to Perform for Others, Compensation Earned 12 month | Research and Development Arrangement, Contract to Perform for Others, Compensation Earned 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $30.00K 10-Q · filed 2026-08-28 | $60.00K derived: sum of 2 quarters · filed 2026-08-28 | $90.00K 10-Q · filed 2026-08-28 | $90.00K derived: sum of 4 quarters · filed 2026-08-28 | ||||
| 2026-03-31 | $30.00K 10-Q · filed 2026-08-28 | $60.00K 10-Q · filed 2026-08-28 | $60.00K derived: sum of 3 quarters · filed 2026-08-28 | $160.00K derived: sum of 4 quarters · filed 2026-08-28 | ||||
| 2025-12-31 | $30.00K 10-Q · filed 2026-02-09 | $30.00K derived: sum of 2 quarters · filed 2026-08-28 | $130.00K derived: sum of 3 quarters · filed 2026-08-28 | $230.00K derived: sum of 4 quarters · filed 2026-08-28 | ||||
| 2025-09-30 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2026-08-28 | $100.00K derived: sum of 2 quarters · filed 2026-08-28 | $200.00K derived: sum of 3 quarters · filed 2026-08-28 | $600.00K 10-K/A · filed 2026-08-28 | ||||
| 2025-06-30 | $100.00K 10-Q · filed 2026-08-28 | $200.00K derived: sum of 2 quarters · filed 2026-08-28 | $600.00K 10-Q · filed 2026-08-28 | $1.30M derived: sum of 4 quarters · filed 2026-08-28 | ||||
| 2025-03-31 | $100.00K 10-Q · filed 2026-08-28 | $500.00K 10-Q · filed 2026-08-28 | $1.20M derived: sum of 3 quarters · filed 2026-08-28 | $1.70M derived: sum of 4 quarters · filed 2026-08-28 | ||||
| 2024-12-31 | $400.00K 10-Q · filed 2026-02-09 | $1.10M derived: sum of 2 quarters · filed 2026-08-28 | $1.60M derived: sum of 3 quarters · filed 2026-08-28 | $2.10M derived: sum of 4 quarters · filed 2026-08-28 | ||||
| 2024-09-30 | $700.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2026-08-28 | $1.20M derived: sum of 2 quarters · filed 2026-08-28 | $1.70M derived: sum of 3 quarters · filed 2026-08-28 | $2.30M 10-K/A · filed 2026-08-28 | ||||
| 2024-06-30 | $500.00K 10-Q · filed 2025-08-12 | $1.00M derived: sum of 2 quarters · filed 2025-08-12 | $1.60M 10-Q · filed 2025-08-12 | $2.30M derived: sum of 4 quarters · filed 2026-08-28 | ||||
| 2024-03-31 | $500.00K 10-Q · filed 2025-05-13 | $1.10M 10-Q · filed 2025-05-13 | $1.80M derived: sum of 3 quarters · filed 2026-08-28 | $2.40M derived: sum of 4 quarters · filed 2026-08-28 | ||||
| 2023-12-31 | $600.00K 10-Q · filed 2025-02-12 | $1.30M derived: sum of 2 quarters · filed 2026-08-28 | $1.90M derived: sum of 3 quarters · filed 2026-08-28 | $2.60M derived: sum of 4 quarters · filed 2026-08-28 | ||||
| 2023-09-30 | $700.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2026-08-28 | $1.30M derived: sum of 2 quarters · filed 2026-08-28 | $2.00M derived: sum of 3 quarters · filed 2026-08-28 | $2.70M 10-K/A · filed 2026-08-28 | ||||
| 2023-06-30 | $600.00K 10-Q · filed 2024-08-06 | $564.84K 10-Q · filed 2023-08-08 | $1.30M derived: sum of 2 quarters · filed 2024-08-06 | $2.00M 10-Q · filed 2024-08-06 | $2.05M 10-Q · filed 2023-08-08 | $2.97M derived: sum of 4 quarters · filed 2024-08-06 | ||
| 2023-03-31 | $700.00K 10-Q · filed 2024-05-09 | $749.68K 10-Q · filed 2023-05-09 | $1.50M 10-Q · filed 2024-05-09 | $1.48M 10-Q · filed 2023-05-09 | $2.37M derived: sum of 3 quarters · filed 2024-05-09 | $3.05M derived: sum of 4 quarters · filed 2024-05-09 | ||
| 2022-12-31 | $700.00K 10-Q · filed 2024-02-07 | $733.59K 10-Q · filed 2023-02-07 | $1.67M derived: sum of 2 quarters · filed 2024-02-07 | $2.35M derived: sum of 3 quarters · filed 2024-02-07 | $3.19M derived: sum of 4 quarters · filed 2024-02-07 | |||
| 2022-09-30 | $971.33K derived: 10-K 12 month − 10-Q 9 month · filed 2023-11-27 | $1.65M derived: sum of 2 quarters · filed 2023-11-27 | $2.49M derived: sum of 3 quarters · filed 2023-11-27 | $3.30M 10-K · filed 2023-11-27 | $3.32M 10-K · filed 2022-11-28 | |||
| 2022-06-30 | $682.43K 10-Q · filed 2023-08-08 | $1.52M derived: sum of 2 quarters · filed 2023-08-08 | $2.33M 10-Q · filed 2023-08-08 | $3.23M derived: sum of 4 quarters · filed 2023-11-27 | ||||
| 2022-03-31 | $835.51K 10-Q · filed 2023-05-09 | $1.65M 10-Q · filed 2023-05-09 | $2.55M derived: sum of 3 quarters · filed 2023-11-27 | $3.92M derived: sum of 4 quarters · filed 2023-11-27 | ||||
| 2021-12-31 | $810.73K 10-Q · filed 2023-02-07 | $1.72M derived: sum of 2 quarters · filed 2023-11-27 | $3.08M derived: sum of 3 quarters · filed 2023-11-27 | $4.04M derived: sum of 4 quarters · filed 2023-11-27 | ||||
| 2021-09-30 | $906.14K derived: 10-K 12 month − 10-Q 9 month · filed 2023-11-27 | $2.27M derived: sum of 2 quarters · filed 2023-11-27 | $3.23M derived: sum of 3 quarters · filed 2023-11-27 | $4.50M 10-K · filed 2023-11-27 | $4.55M 10-K · filed 2021-11-24 | |||
| 2021-06-30 | $1.36M 10-Q · filed 2022-08-09 | $2.32M derived: sum of 2 quarters · filed 2022-08-09 | $3.59M 10-Q · filed 2022-08-09 | $4.99M derived: sum of 4 quarters · filed 2022-11-28 | ||||
| 2021-03-31 | $960.88K 10-Q · filed 2022-05-10 | $2.23M 10-Q · filed 2022-05-10 | $3.62M derived: sum of 3 quarters · filed 2022-11-28 | $4.94M derived: sum of 4 quarters · filed 2022-11-28 | ||||
| 2020-12-31 | $1.27M 10-Q · filed 2022-02-09 | $2.66M derived: sum of 2 quarters · filed 2022-11-28 | $3.98M derived: sum of 3 quarters · filed 2022-11-28 | $4.70M derived: sum of 4 quarters · filed 2022-11-28 | ||||
| 2020-09-30 | $1.39M derived: 10-K 12 month − 10-Q 9 month · filed 2022-11-28 | $2.71M derived: sum of 2 quarters · filed 2022-11-28 | $3.43M derived: sum of 3 quarters · filed 2022-11-28 | $4.38M 10-K · filed 2022-11-28 | ||||
| 2020-06-30 | $1.32M 10-Q · filed 2021-08-12 | $2.04M derived: sum of 2 quarters · filed 2021-08-12 | $2.98M 10-Q · filed 2021-08-12 | $3.47M derived: sum of 4 quarters · filed 2021-08-12 | ||||
| 2020-03-31 | $717.33K 10-Q · filed 2021-05-13 | $510.99K 10-Q · filed 2020-05-07 | $1.66M 10-Q · filed 2021-05-13 | $717.33K 10-Q · filed 2020-05-07 | $2.15M derived: sum of 3 quarters · filed 2021-05-13 | $2.70M derived: sum of 4 quarters · filed 2021-05-13 | ||
| 2019-12-31 | $943.22K 10-Q · filed 2021-02-16 | $1.43M derived: sum of 2 quarters · filed 2021-02-16 | $1.98M derived: sum of 3 quarters · filed 2021-02-16 | $2.91M derived: sum of 4 quarters · filed 2021-02-16 | ||||
| 2019-09-30 | $488.68K derived: 10-K 12 month − 10-Q 9 month · filed 2020-12-28 | $1.04M derived: sum of 2 quarters · filed 2020-12-28 | $1.97M derived: sum of 3 quarters · filed 2020-12-28 | $2.22M 10-K · filed 2020-12-28 | ||||
| 2019-06-30 | $552.34K 10-Q · filed 2020-08-06 | $1.48M derived: sum of 2 quarters · filed 2020-08-06 | $1.73M 10-Q · filed 2020-08-06 | $1.66M 10-Q · filed 2019-08-07 | ||||
| 2019-03-31 | $924.67K 10-Q · filed 2020-05-07 | $1.66M 10-Q · filed 2020-05-07 | ||||||
| 2018-12-31 | $413.68K 10-Q · filed 2020-02-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |